How Insurance Coverage Works for Weight-Loss Medication
Whether a weight-management medication is covered depends on your specific plan’s formulary, not on the drug alone. Many employer and marketplace plans exclude weight-loss drugs as a category, while covering the same active ingredient when it is prescribed for an approved non-weight indication such as type 2 diabetes. The reliable way to find out is to look up the drug in your plan’s formulary and call the member services number on your insurance card.
Key facts
- Coverage is indication-specific: a plan may cover Ozempic for type 2 diabetes and exclude Wegovy for weight management.
- Prior authorization is common — your prescriber submits clinical documentation before the plan will pay.
- Medicare Part D is statutorily prohibited from covering drugs used for weight loss; coverage may exist for other approved indications of the same product.
- Medicaid coverage of weight-management drugs varies state by state.
- A denial can be appealed; plans are required to provide an appeals process.
Step one: find your plan’s formulary
A formulary is the list of drugs a plan covers and the tier each sits on. It is plan-specific — two people with the same insurer can have different formularies. Your formulary is available through your insurer’s member portal, and the member services number on your insurance card can confirm coverage for a specific drug and indication.
- Search the formulary for the exact brand name, not the ingredient
- Note the tier and any restrictions listed (PA = prior authorization, ST = step therapy, QL = quantity limit)
- Ask specifically about the indication your prescriber will document
Why prior authorization exists and what it involves
Prior authorization means the plan requires clinical justification before covering the drug. For weight-management medications, plans commonly ask for documentation such as body mass index, weight-related conditions, and sometimes documented attempts at lifestyle intervention.
Your prescriber’s office submits this. If it is denied, you have the right to appeal, and the denial letter must explain how.
Medicare and Medicaid
Federal law excludes "agents when used for weight loss" from Medicare Part D coverage. In 2024, CMS issued guidance that Part D plans may cover a drug that receives an additional medically accepted indication beyond weight loss — for example, Wegovy’s cardiovascular risk-reduction indication — for beneficiaries who meet that indication.
Medicaid coverage of weight-management drugs is a state-by-state decision. Check your state Medicaid program’s current policy.
If you are not covered
Manufacturer savings programs, self-pay channels operated by manufacturers, and pharmacy price comparison are the common routes. Terms and prices change frequently — verify directly with the manufacturer and pharmacies rather than relying on any figure published elsewhere, including here.
Medications discussed in this guide
Sources
- CMS: Medicare Prescription Drug Benefit Manual — CMS. Link last verified August 12, 2026.
- Medicare.gov: drug coverage (Part D) — CMS. Link last verified August 12, 2026.
- Medicaid.gov: prescription drugs — CMS. Link last verified August 12, 2026.
Not medical advice. WeightLossDrugsGuide is an independent educational publisher. We are not a pharmacy, a medical provider, or a telehealth clinic, and we do not provide personalized medical recommendations or dosing guidance. Information here summarizes official FDA labeling and other primary sources and may not reflect the most recent changes. Always talk with a licensed clinician about your own situation, and read the full prescribing information for any medication.